Lukasz Durko (L Durko)

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 4

Top Topics

Peritoneal Dialysis

Magnetic Resonance

Cancer Stem Cells

Binding Protein

Top Venues

Disease markers

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Barbara Wlodarczyk, Lukasz Durko, Przemysław Włodarczyk, Renata Talar-Wojnarowska, Ewa Małecka-Panas
CA 19-9 but Not IGF-1/IGFBP-2 Is a Useful Biomarker for Pancreatic Ductal Adenocarcinoma (PDAC) and Chronic Pancreatitis (CP) Differentiation. Journal of clinical medicine 12 (12) (2023)
Barbara Wlodarczyk, Lukasz Durko, Przemysław Włodarczyk, Renata Talar-Wojnarowska, Ewa Małecka-Panas
CA 19-9 but Not IGF-1/IGFBP-2 Is a Useful Biomarker for Pancreatic Ductal Adenocarcinoma (PDAC) and Chronic Pancreatitis (CP) Differentiation. Journal of clinical medicine 12 (12) (2023)
Lukasz Durko, W Wlodarski, O Stasikowska-Kanicka, Marian Danilewicz, Malgorzata Wagrowska-Danilewicz, Piotr Hogendorf, Janusz Strzelczyk, E Malecka-Panas
Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis. Disease markers 2017 (2017)
Lukasz Durko, W Wlodarski, O Stasikowska-Kanicka, Malgorzata Wagrowska-Danilewicz, Marian Danilewicz, Piotr Hogendorf, Janusz Strzelczyk, E Malecka-Panas
Corrigendum to "Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis". Disease markers 2017 (2017)